BIIB
Biogen IncNASDAQHEALTHCAREDRUG MANUFACTURERS - GENERAL
Key Statistics
Market Cap
$27.76B
P/E Ratio
21.50
EPS
$8.80
Beta
0.14
52W High
$202.41
52W Low
$110.04
50-Day MA
$184.31
200-Day MA
$156.87
Dividend Yield
—
Profit Margin
13.10%
Forward P/E
12.05
PEG Ratio
3.71
About Biogen Inc
Biogen Inc. is an American multinational biotechnology company based in Cambridge, Massachusetts, specializing in the discovery, development, and delivery of therapies for the treatment of neurological diseases to patients worldwide.
Fundamentals
| Revenue (TTM) | $9.89B |
| Gross Profit (TTM) | $7.81B |
| EBITDA | $3.60B |
| Operating Margin | 19.60% |
| Return on Equity | 7.39% |
| Return on Assets | 6.14% |
| Revenue/Share (TTM) | $67.51 |
| Book Value | $124.36 |
| Price-to-Book | 1.52 |
| Price-to-Sales (TTM) | 2.81 |
| EV/Revenue | 3.086 |
| EV/EBITDA | 11.72 |
| Quarterly Earnings Growth (YoY) | 19.20% |
| Quarterly Revenue Growth (YoY) | -7.10% |
| Shares Outstanding | $146.76M |
| Float | $146.28M |
| % Insiders | 0.17% |
| % Institutions | 98.06% |
Historical Volatility
HV 10-Day
27.85%
HV 20-Day
28.40%
HV 30-Day
26.34%
HV 60-Day
35.79%
HV Rank
11.1%
Volatility is currently expanding
Analyst Ratings
Consensus ($205.90 target)
1
Strong Buy14
Buy20
Hold1
SellData last updated: 3/26/2026